High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura

Haematologica

Volumn 94, Issue 11, 2009, Pages 1603-1607

  Shan, Ning Ning ^a   Zhu, Xiao Juan ^a   Wang, Qian ^a   Wang, Chun Yan ^a   Qin, Ping ^a   Peng, Jun ^a   Hou, Ming ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

High dose dexamethasone; Idiopathic thrombocytopenic purpura; Interleukin 18; Interleukin 18 binding protein

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 4; MESSENGER RNA; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; YOUNG ADULT;

EID: 70449359645     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.007708     Document Type: Article

References (19)

1. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-623 (Pubitemid 27175429)
2. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-gamma inducing factor mediated by interleukin- 1β converting enzyme. Science 1997;275:206-209 (Pubitemid 27034760)
3. Reddy P. Interleukin-18: recent advances. Curr Opin Hematol 2004;11:405-410
4. Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-g-induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein β. Proc Natl Acad Sci USA 2002;99:16957-16962 (Pubitemid 36034080)
5. Coopamah MD, Garvey MB, Freedman J, Semple JW. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev 2003;17:69-80. (Pubitemid 36042646)
6. McMillan R. Antigen-specific assays in immune thrombocytopenia. Transfus Med Rev 1990;4:136-143
7. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991;78:2619-2625
8. Semple JW, Milev Y, Cosgrave D, Mody M, Hornstein A, Blanchette V, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996;87:4245-4254 (Pubitemid 26152268)
9. Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004;103:2645-2647 (Pubitemid 38393019)
10. Shan NN, Zhu XJ, Peng J, Qin P, Zhuang XW, Wang HC, et al. Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura. Br J Haematol 2009;144:755-761
11. Rodeghiero F. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Eur J Haematol Suppl 2008;69:19-26.
12. Cheng Y, Wong RS, Soo YO, Chui CH, Lau FY, Chan NP, et al. Initial treatment of immune thrombocytopenic purpura with highdose dexamethasone. N Engl J Med 2003;349:831-836 (Pubitemid 37025402)
13. Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L, et al.Therapy with high-dose dexamethasone (HDDXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura. A GIMEMA experience. Blood 2007;109:1401-1407 (Pubitemid 46239570)
14. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology 2003;120:574-596
15. Michael W, Graham W, Dempfle HL. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 2002;30:1-10.
16. Guo CS, Chu XX, Shi Y, He W, Li L, Wang L, et al. Correction of Th1- dominant cytokine profiles by highdose dexamethasone in patients with chronic Idiopathic thrombocytopenic purpura. J Clin Immunol 2007;27:557-562
17. + lymphocytes by inhibiting IL-12 production. J Immunol 1998;160:2231-2237
18. Peng J, Liu CF, Liu D, Ren C, Li W, Wang Z, et al. Effects of B7- blocking agent and/or CsA on induction of platelet-specific T-cell anergy in chronic autoimmune thrombocytopenic purpura. Blood 2003;101:2721-2726 (Pubitemid 36857635)
19. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 1995;268:331-338